ProteiQ is a next-generation LC-MS proteomics provider. As a CRO, we partner with pharmaceutical companies and academic groups in biomarker and drug research during discovery, preclinical and early clinical phases.
ProteiQ began as a biomarker research company. Realising early the significance of bioinformatics for next-generation proteomics, we developed a world-leading, scalable computational platform for DIA-MS data processing.
By the end of 2018, ProteiQ expanded into a full-service proteomics CRO, opening a wet-lab facility in Potsdam. Since then, we have implemented in-house QC and R&D processes, optimised each step of proteomic analysis.
.png)
At ProteiQ, we believe in the transformational power of LC-MS proteomics. Following our motto, “Analyse what matters”, we focus on proteins—because we believe their proximity to expressed phenotype holds the keys to understanding biology, and enabling personalised medicine.
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
ProteiQ’s approach is based on scientific rigour; we collect dependable data, working with precision to deliver results. All our services are personalised and adapted to each project—ensuring our commitment to every customer worldwide.
We use cutting-edge technology, providing data you can trust.
We decide based on data; that’s our code and our work.
We prize personalization, both for our projects and the world.
We work as a team—within our company, and with our clients.
We emphasise what matters: creating impact through results.
Single-shot proteomics
Deep proteomics
IP-MS
DeNovo Sequencing
Phosphoproteomics
Targeted analysis (PRM/MRM/SRM)
Cells
Tissue
Plasma
Other biofluids
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Single-shot proteomics
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Deep proteomics
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
IP-MS
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
DeNovo Sequencing
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Targeted analysis (PRM/MRM/SRM)
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Cells
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Tissue
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Plasma
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Other biofluids
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Phosphoproteomics
Our purpose is to provide researchers with a cutting-edge gateway to proteomes to achieve next breakthroughs in life sciences —whether in academia, small or large pharmaceutical companies.
Single-shot proteomics
Through collaborative spirit and profound in-house expertise in each step of proteomic analysis, we enable our customers to achieve scientific breakthroughs in biology and personalised medicine.
%20(1).svg)